You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
AI-Driven Formative Assessments for Hands-on Science
SBC: MYRIAD SENSORS, INC. Topic: 91990020R0006With Phase I and Phase II funding from prior IES-funded SBIR project, the developer created a wireless device that transmits scientific data from hands-on experiments carried out by middle school students to a dashboard that presents results from student work in real-time. This project will develop an artificial intelligence (AI) assessment system that will provide immediate personalized feedback ...
SBIR Phase I 2020 Department of EducationInstitute of Education Sciences -
Algorithmic Solutions for Third Party Low-Cost Sensing of LPBF
SBC: QUARTUS ENGINEERING INCORPORATED Topic: DLA193002Quartus’ Neural Networks for In-situ Inspection of LPBF (NNIIL) program leverages the latest machine learning and convolutional neural network (CNN) methods to perform data processing of manufacturing information captured during in-situ inspection of laser powder bed fusion (LPBF) parts. This methodology has the potential to generate more accurate flaw detection results with much less developmen ...
SBIR Phase I 2020 Department of DefenseDefense Logistics Agency -
Black Carbon and UV Particulate Matter, Multi-gas, Multi-pollutant Sensor Platform
SBC: MICROAETH CORPORATION Topic: 19NCERP2As wildfires are increasing in prevalence and intensity there is a need for miniaturized, lower cost, and easily portable air sensor systems that provide accurate information to air quality and public health managers, communities, and researchers, so that the public can be protected and timely decisions can be made. Fixed site measurement stations are large and expensive. More dense networks of sm ...
SBIR Phase II 2020 Environmental Protection Agency -
Cost-effective, portable and automated platform for microplastics characterization
SBC: LUCENDI INC Topic: 19NCER1AAn estimated 75% of litter along the shoreline globally is made of plastic. Plastic particles and debris find their way into oceans, rivers, lakes, sediment, and eventually into our bodies. Over 90% of the plastic contamination in the open ocean is attributed to microplastic particles (MP) - i.e. plastic objects with diameter
SBIR Phase I 2020 Environmental Protection Agency -
Development of a Non-invasive Negative Ophthalmodynamometer Capable of Measuring Intracranial Pressure in Humans
SBC: Equinox Ophthalmic, Inc. Topic: CBD192005Measurement of intracranial pressure (ICP) is essential in the diagnosis and management of numerous life threatening conditions. All current methods used clinically to measure ICP are invasive and require direct access to the cerebrospinal fluid giving them a significant side effect profile. The ability to measure ICP non-invasively would be a major milestone for patients. Spontaneous venous pulsa ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Development of Simple, Field-Deployable Kit for Detecting Antibiotic Resistant Bacteria in Wastewater
SBC: SCIENTIFIC METHODS INC Topic: 19NCER1EAntibiotic resistant bacteria have become a major concern in discharges from hospitals, wastewater treatment plants, and agricultural runoff. A quick, inexpensive, field- deployable method of detecting antibiotic resistant bacteria in these waters is desirable. Antibiotic resistant bacteria of concern include Salmonella, Staphylococci, E. coli, Enterococci, and coliform bacteria, among others. A p ...
SBIR Phase I 2020 Environmental Protection Agency -
Development of Small Molecule Therapeutics for Emerging Viral Agents
SBC: ARISAN THERAPEUTICS INC Topic: CBD192006Arenaviruses comprise a diverse group of Old (Africa) and New World (Americas) species. Several species are associated with hemorrhagic fever (HF) with case-fatality rates as high as 30%. Arenaviruses infection typically occurs via the mucosal route through contact with excretions of an infected rodents although direct human-to-human transmission may occur in clinical settings. Lassa arenavirus en ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Development of Small Molecule Therapeutics for Emerging Viral Agents
SBC: ARISAN THERAPEUTICS INC Topic: CBD192006Ebolavirus species including Zaire (EBOV), Sudan (SUDV) and Bundibugyo (BDBV) are responsible for severe hemorrhagic fever outbreaks with high case fatalities in Africa. Weaponized pathogens present an additional threat to the health protection of the warfighter and first-generation prophylactic and therapeutic medical countermeasures (MCMs) may prove inadequate in biodefense settings. Ebolaviruse ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
3D Printed Manufacturing of Respiratory Protection
SBC: AKITA INNOVATIONS LLC Topic: CBD181001The principal benefit of this project will be the development of materials, processes and designs for the additive manufacture of air purifying respirators. Additive manufacture allows mass personalization of existing systems. For respirators, that design is the unique size and facial structure of each individual warfighter. The ability to personalize respirator design to each unique warfighter wi ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Dual Formulation of Atropine/Scopolamine with Enhanced Stability
SBC: Nano Terra, Inc. Topic: CBD181005The standard US military treatment for nerve agent exposure is application of up to three autoinjectors, each containing atropine sulfate and 2-pralidoxime, to counteract symptoms of nerve agent intoxication and restore acetylcholinesterase activity. This treatment increases survival rates after nerve agent exposure, however, seizures resulting from nerve agent poisoning are a common symptom that ...
SBIR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense